Gene 156:123127
Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis
Today, the flagship BSCG Certified Drug Free program requires a GMP compliance review and third-party audit, verification of label claims and contaminant testing, and comprehensive testing of every lot for more than 530 banned substances
doi: 10.1016/j.expneurol.2017.03.012
Implicating the role of lycopene in restoration of mitochondrial enzymes and BDNF levels in -amyloid induced Alzheimers disease
Water, butylene glycol (1,3, butanediol), tocofersolan, hyaluronic acid, ethanol, caprylyl glycol, medium chain triglycerides, copper tripeptide-1 (GHK-Cu), highly purified phospholipids, natural mixed tocopherols, Psoralea corylifolia seed/leaf extract (Bakuchiol), tetrahexyldecyl ascorbate, lavender essential oil, Curcumin C3 Reduct (turmeric rhizome extract) (standardized to 95% tetrahydrocurcuminoids), Astragalus membranaceus root extract (standardized to 98% cyclosastragenol)
